Cargando…
Plasma miRNAs as Biomarkers to Identify Patients with Castration-Resistant Metastatic Prostate Cancer
MicroRNAs (miRNAs) have emerged as key regulators of numerous biological processes, and increasing evidence suggests that circulating miRNAs may be useful biomarkers of clinical disease. In this study, we sought to identify plasma miRNAs that differentiate patients with metastatic castration resista...
Autores principales: | Watahiki, Akira, Macfarlane, Robyn J., Gleave, Martin E., Crea, Francesco, Wang, Yuzhuo, Helgason, Cheryl D., Chi, Kim N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3645714/ https://www.ncbi.nlm.nih.gov/pubmed/23574937 http://dx.doi.org/10.3390/ijms14047757 |
Ejemplares similares
-
MicroRNAs Associated with Metastatic Prostate Cancer
por: Watahiki, Akira, et al.
Publicado: (2011) -
Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer
por: Crea, Francesco, et al.
Publicado: (2014) -
Integrated analysis of the prostate cancer small‐nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progression
por: Crea, Francesco, et al.
Publicado: (2015) -
Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients
por: Endzeliņš, Edgars, et al.
Publicado: (2017) -
Plasma exosomal miRNAs-based prognosis in metastatic kidney cancer
por: Du, Meijun, et al.
Publicado: (2017)